Support the fact-based journalism you rely on with a donation to Marketplace today. Give Now!

New class of generics could save consumers, insurers billions. FDA is moving carefully.

Jul 13, 2016
The European Union has some 20 "biosimilar" generics on the market; the US has one.
Pre-filled syringes of  the adalimumab biosimilar.  The biosimilar is used in the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis and ankylosing spondylitis.
SAM PANTHAKY/AFP/Getty Images

'Biosimilar' drug launches for first time in U.S.

Sep 4, 2015
The new type of generic drug could reduce costs of cutting-edge medicines.